Real World Outcomes of Adding Rapid-Acting Insulin Versus Switching to Analog Premix Insulin Among US Patients With Type 2 Diabetes Treated With Insulin Glargine
Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s49287
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Publisher
Informa UK Limited